LUMAKRAS (sotorasib) tablets. FDA Approved
LUMAKRAS (sotorasib) tablets
INDICATIONS AND USAGE
LUMAKRAS is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
This indication is approved under accelerated approval based on overall response rate (ORR) and duration of response (DOR). Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
DOSAGE FORMS & STRENGTHS: Tablets: 120 mg.
Manufactured By: Amgen Inc.
Prescribing Information URL: Click Here
HOW TO MAKE AN ENQUIRY FOR LUMAKRAS (sotorasib) tablets?
FDA approved Anti-Cancer medicine LUMAKRAS (sotorasib) tablets is available upon request. To get best retail price of LUMAKRAS (sotorasib) tablets India, For emergency product orders call 8750295029 (Mr. Neeraj Nagpal) or For enquires email email@example.com For advanced treatments in India, Medvitaz Pharma Solution can even help patient to discuss with pulmonologist.